Jidong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jidong Wang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Yixin Qu
Beijing Key Laboratory of Membrane Science and Technology, College of Chemical Engineering, Beijing University of Chemical Technology, Beijing 100029, P. R. China
7 shared publications Shui Wang
Beijing Key Laboratory of Membrane Science and Technology, College of Chemical Engineering, Beijing University of Chemical Technology, Beijing 100029, P. R. China
3 shared publicationsYixin Qu
Beijing Key Laboratory of Membrane Science and Technology, College of Chemical Engineering, Beijing University of Chemical Technology, Beijing, P. R. China
3 shared publicationsChengxuan Fang
College of Chemical Engineering, Beijing University of Chemical Technology
2 shared publications- Teng He
Beijing University of Chemical Technology
2 shared publications Yongkun Zhang
Beijing Key Laboratory of Membrane Science and Technology, College of Chemical Engineering, Beijing University of Chemical Technology, Beijing, P. R. China
2 shared publications
Latest Publications
- Open Access
- 14 November 2025
- Published by Association for Computing Machinery (ACM)
- p. 95-100
Deep Learning-Based Kinetic Modeling for Methanol Synthesis from Syngas
- 14 November 2025
- Published by Association for Computing Machinery (ACM)
- p. 95-100
Open AccessDeep Learning-Based Kinetic Modeling for Methanol Synthesis from Syngas
- 20 April 2021
- Published by American Chemical Society (ACS) in Journal of Chemical & Engineering Data
- Vol. 66 (5) , 1877-1889
Solubility Determination and Thermodynamic Modeling of Amitriptyline Hydrochloride in 13 Pure Solvents at Temperatures of 283.15–323.15 K
- 20 April 2021
- Published by American Chemical Society (ACS) in Journal of Chemical & Engineering Data
- Vol. 66 (5) , 1877-1889
Solubility Determination and Thermodynamic Modeling of Amitriptyline Hydrochloride in 13 Pure Solvents at Temperatures of 283.15–323.15 K
- 26 September 2019
- Published by American Chemical Society (ACS) in Journal of Chemical & Engineering Data
- Vol. 64 (10) , 4565-4579
Solubility and Thermodynamic Modeling of Dimethyl Terephthalate in Pure Solvents and the Evaluation of the Mixing Properties of the Solutions
- 26 September 2019
- Published by American Chemical Society (ACS) in Journal of Chemical & Engineering Data
- Vol. 64 (10) , 4565-4579
Solubility and Thermodynamic Modeling of Dimethyl Terephthalate in Pure Solvents and the Evaluation of the Mixing Properties of the Solutions
- 5 June 2019
- Published by American Chemical Society (ACS) in Journal of Chemical & Engineering Data
- Vol. 64 (7) , 3128-3138
Measurement and Correlation of Solubility of Hydrochlorothiazide in Monosolvents and Binary Solvent Mixtures from 283.15 to 323.15 K
- 5 June 2019
- Published by American Chemical Society (ACS) in Journal of Chemical & Engineering Data
- Vol. 64 (7) , 3128-3138
Measurement and Correlation of Solubility of Hydrochlorothiazide in Monosolvents and Binary Solvent Mixtures from 283.15 to 323.15 K
- 14 November 2018
- Published by Springer Nature in Catalysis Letters
- Vol. 149 (2) , 373-389
Aldol Condensation Reaction of Methyl Acetate and Formaldehyde Over Cesium Oxide Supported on Silica Gel: An Experimental and Theoretical Study
- 14 November 2018
- Published by Springer Nature in Catalysis Letters
- Vol. 149 (2) , 373-389
Aldol Condensation Reaction of Methyl Acetate and Formaldehyde Over Cesium Oxide Supported on Silica Gel: An Experimental and Theoretical Study
- 22 March 2018
- Published by Taylor & Francis in Petroleum Science and Technology
- Vol. 36 (12) , 898-903
Effect of crystal size on the catalytic performance of HZSM-5 Zeolite in the methanol to aromatics reaction
The effect of crystal size on the lifetime and product distribution of HZSM-5 catalysts in methanol to aromatics reaction has been investigated. Increasing crystal size results in a reduction of the lifetime. Though the initial selectivity of total aromatics is approximately the same, larger crystal size favors the dealkylation reactions of polymethylbenzenes, cracking of C5–C9 non-aromatics and hydrogen transfer reaction, leading to different product distribution. The longer lifetime of HZSM-5 with smaller crystal size can be attributed to its larger specific surface area, pore volume and diameter and short residence time of the reaction products in the zeolite pores.
- 22 March 2018
- Published by Taylor & Francis in Petroleum Science and Technology
- Vol. 36 (12) , 898-903
Effect of crystal size on the catalytic performance of HZSM-5 Zeolite in the methanol to aromatics reaction
The effect of crystal size on the lifetime and product distribution of HZSM-5 catalysts in methanol to aromatics reaction has been investigated. Increasing crystal size results in a reduction of the lifetime. Though the initial selectivity of total aromatics is approximately the same, larger crystal size favors the dealkylation reactions of polymethylbenzenes, cracking of C5–C9 non-aromatics and hydrogen transfer reaction, leading to different product distribution. The longer lifetime of HZSM-5 with smaller crystal size can be attributed to its larger specific surface area, pore volume and diameter and short residence time of the reaction products in the zeolite pores.
- 19 February 2018
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 57 (8) , 2773-2786
Experimental and Theoretical Study for Vapor Phase Aldol Condensation of Methyl Acetate and Formaldehyde over Alkali Metal Oxides Supported on SBA-15
- 19 February 2018
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 57 (8) , 2773-2786
Experimental and Theoretical Study for Vapor Phase Aldol Condensation of Methyl Acetate and Formaldehyde over Alkali Metal Oxides Supported on SBA-15
- 30 October 2017
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 56 (44) , 12508-12519
Cadmium Modified HZSM-5: A Highly Efficient Catalyst for Selective Transformation of Methanol to Aromatics
- 30 October 2017
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 56 (44) , 12508-12519
Cadmium Modified HZSM-5: A Highly Efficient Catalyst for Selective Transformation of Methanol to Aromatics
- 1 May 2014
- Published by China Journal of Chinese Materia Medica in China Journal of Chinese Materia Medica
- Vol. 41 (9) , 1744-1753
Systematic review on safety of Xinyuan capsules
To systematically review the adverse drug reactions/adverse events(ADRs/AEs) of Xinyuan capsules in clinical application. A systematic literature search was performed in the databases of the Cochrane Library, Medline, EMBASE, the Web of Science, Clinical trials, CNKI, VIP, WanFang Data and CBM. The literature was screened and data was extracted according to the inclusion and exclusion criteria. Because of the substantial heterogeneity among different studies, we assessed them only with descriptive analysis by study type, disease diagnosis, and ADRs/AEs conditions. All included studies were assessed by using the internationally recognized report quality evaluation standard or methodological quality assessment tools. A total of 42 studies involving 3 671 patients were included finally. Two thouand four hundred and thirty-mine patients of them took Xinyuan capsules, and 1 242 patients did not take Xinyuan capsules. No serious ADRs occurred in all patients. One patient died as AE during the research. Sixteen patients of the 2 439 patients taking Xinyuan capsules (alone or in combination) had ADRs, including 7 patients with polytherapy of Xinyuan capsules and 9 patients with monotherapy. The most common ADRs were in gastrointestinal tract, mainly including thirst, nausea, vomiting and abdominal pain, etc. The ADRs included 10 gastrointestinal tract ADRs, 3 renal ADRs and 1 ADR respective in skin system, respiratory system and cardiovascular system. Xinyuan capsules was generally safe in clinical application. The reports on the study of Xinyuan capsules were dispersed in various clinical studies, the study on drug safety still should be strengthened in the future. Further mechanism studies or clinical observation studies of the drug safety shall be conducted to better guide clinical application in the future.
- 1 May 2014
- Published by China Journal of Chinese Materia Medica in China Journal of Chinese Materia Medica
- Vol. 41 (9) , 1744-1753
Systematic review on safety of Xinyuan capsules
To systematically review the adverse drug reactions/adverse events(ADRs/AEs) of Xinyuan capsules in clinical application. A systematic literature search was performed in the databases of the Cochrane Library, Medline, EMBASE, the Web of Science, Clinical trials, CNKI, VIP, WanFang Data and CBM. The literature was screened and data was extracted according to the inclusion and exclusion criteria. Because of the substantial heterogeneity among different studies, we assessed them only with descriptive analysis by study type, disease diagnosis, and ADRs/AEs conditions. All included studies were assessed by using the internationally recognized report quality evaluation standard or methodological quality assessment tools. A total of 42 studies involving 3 671 patients were included finally. Two thouand four hundred and thirty-mine patients of them took Xinyuan capsules, and 1 242 patients did not take Xinyuan capsules. No serious ADRs occurred in all patients. One patient died as AE during the research. Sixteen patients of the 2 439 patients taking Xinyuan capsules (alone or in combination) had ADRs, including 7 patients with polytherapy of Xinyuan capsules and 9 patients with monotherapy. The most common ADRs were in gastrointestinal tract, mainly including thirst, nausea, vomiting and abdominal pain, etc. The ADRs included 10 gastrointestinal tract ADRs, 3 renal ADRs and 1 ADR respective in skin system, respiratory system and cardiovascular system. Xinyuan capsules was generally safe in clinical application. The reports on the study of Xinyuan capsules were dispersed in various clinical studies, the study on drug safety still should be strengthened in the future. Further mechanism studies or clinical observation studies of the drug safety shall be conducted to better guide clinical application in the future.